首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1709451

流動止血鉗市場，按產品類型、應用、最終用戶、國家和地區 - 2025 年至 2032 年全球產業分析、市場規模、市場佔有率及預測

Flowable Hemostats Market, By Product Type, By Application, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日期: 2025年03月04日 | 出版商:

AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告重點

2024 年流動止血鉗市場規模價值 7.5054 億美元，2025 年至 2032 年的複合年成長率為 6.01%。

止血技術的進步，例如更快的應用和更好的生物相容性，正在提高其有效性。此外，微創手術的需求也促進了流動止血鉗的使用。目前，北美和歐洲憑藉先進的醫療保健體系引領市場，而亞太地區正經歷快速成長。挑戰包括高成本和監管障礙。然而，不斷增加的醫療保健投資和創新繼續推動市場擴張。

流動止血鉗市場-市場動態

全球範圍內外科手術的增加增加了對止血解決方案的需求。

全球範圍內外科手術數量的不斷增加是推動流動止血鉗市場發展的重要因素。《柳葉刀》雜誌發表的一項研究估計，全球每年約進行 2.34 億次大型外科手術。如此高的出血量凸顯了對有效止血劑控制手術期間出血的迫切需求。

流動止血鉗以其易於使用和有效控制出血而聞名，正在成為手術工具包中必不可少的工具。隨著全球人口老化和慢性病盛行率上升，預計對外科手術的需求將會增加，進一步推動先進止血解決方案的需求。

流動止血鉗市場-關鍵見解

根據我們的研究分析師的分析，預測期內（2025-2032 年）全球市場預計年複合成長率約為 6.01%

根據產品類型細分，預計明膠止血劑將在 2024 年佔據最大市場佔有率

根據應用細分，心血管手術是 2024 年的主要應用

根據最終用戶細分，醫院是 2024 年領先的最終用戶

按地區分類，北美是 2024 年的主要收入來源

流動止血鉗市場-細分分析：

全球流動止血鉗市場根據產品類型、應用、最終用戶和地區進行細分。

根據產品類型，市場分為四類：明膠基止血劑、膠原基止血劑、組合止血劑和凝血酶基止血劑。明膠基止血劑因其多功能性、有效性以及在各種外科手術過程中控制出血的易用性而佔據流動止血劑市場主導地位。這些止血劑透過快速吸收血液並形成機械屏障來促進凝血。它們在心血管、骨科和普通外科手術中的廣泛應用推動了它們的市場領先地位。根據美國食品藥物管理局（FDA）的說法，明膠止血劑是手術室中最常使用的止血劑之一。外科醫生更喜歡它們，因為它們具有生物相容性、易於應用，並且對不規則傷口表面有效。此外，微創手術和創傷病例的不斷增加進一步刺激了它們的需求。配方改進、吸收率加快等持續進步正在提高其性能，鞏固其市場領先地位。

根據應用，市場分為兩類：心血管外科、骨科手術、一般外科、神經外科、婦科手術、泌尿科、其他。心血管手術佔據了流動止血鉗市場的主導地位，因為大量複雜的手術需要有效的止血。根據美國疾病管制與預防中心 (CDC) 的數據，美國每年約有 805,000 例心臟病發作，導致心臟手術數量激增。在這些手術中，流動止血鉗對於控制脆弱和難以觸及的區域的出血至關重要，可以降低併發症的風險。外科醫生更喜歡它們，因為它們能夠在不規則表面和活動性出血部位進行手術。心臟病盛行率的不斷上升、人口老化以及心臟搭橋手術和瓣膜置換等心臟手術的進步進一步刺激了需求。微創心血管介入的轉變增加了快速有效的止血解決方案的使用，鞏固了心血管外科手術作為主要應用領域的地位。

流動止血鉗市場—地理洞察

受大量外科手術和先進的醫療保健基礎設施的推動，北美佔據了流動止血鉗市場的大部分佔有率。根據美國疾病管制與預防中心 (CDC) 的數據，美國每年進行超過 5,000 萬例手術，對有效止血解決方案的需求不斷增加。該地區受益於 FDA 的頻繁批准，這有助於引進創新的止血產品。心血管疾病和癌症等慢性疾病的日益流行，增加了手術的數量，進一步推動了市場的成長。此外，老年人口的增加使得他們更容易接受外科手術干預，這也增加了對先進止血劑的需求。強生、百特和美敦力等主要公司正大力投資研發以提高產品功效。門診手術和微創手術的增加（尤其是在門診手術中心）也刺激了需求。總體而言，強勁的醫療保健支出和技術進步使北美成為流動止血劑的關鍵市場。

由於外科手術量大和醫療設施先進，美國在流動止血鉗市場佔有相當大的佔有率。據美國疾病管制與預防中心稱，美國每年進行超過 5,000 萬例手術，對有效止血解決方案的需求不斷增加。強生、百特和美敦力等主要參與者透過持續創新和新產品推出促進了市場成長。此外，人口老化日益加劇以及心血管疾病和癌症等慢性疾病的發生率不斷上升，也推動了外科手術的介入。該國強大的監管框架以及 FDA 的頻繁批准支持了先進止血產品的快速採用。醫療保健研究資金的增加和高額的醫療保健支出進一步推動了市場擴張。門診和微創手術的增加，特別是在門診手術中心，增加了對易於使用的止血鉗的需求。此外，事故造成的創傷也導致緊急手術中流動止血鉗的使用增加。總體而言，美國仍然是一個具有強勁成長潛力的關鍵市場。

流動止血鉗市場-競爭格局：

流動止血鉗市場競爭激烈，受技術進步、產品創新和主要參與者之間的策略合作的推動。本公司正專注於研發，推出療效更高、應用更快、生物相容性更好的止血解決方案。 FDA 的頻繁批准和新產品的推出正在促進市場擴張。合併、收購以及與醫院和外科中心的合作是加強市場影響力的常見策略。強生公司（Ethicon）、百特國際（Floseal Hemostatic Matrix）、碧迪公司（BD）、美敦力和輝瑞等領導者憑藉廣泛的止血解決方案佔領了市場。此外，Stryker、Teleflex、CryoLife、CSL Behring、Hemostasis、LLC 和 Tissuemed Ltd 等公司也在透過持續創新擴大其產品組合。對微創手術技術的投資以及與醫療保健提供者的合作進一步塑造了競爭格局。激烈的競爭推動了產品性能、安全性和可訪問性的提高，確保了市場持續成長。

介紹
- 按地區分類的細分市場佔有率分析
北美洲
- 概述
- 北美流動止血鉗主要製造商
- 北美市場規模及預測（按國家/地區）
- 北美市場規模和預測（按產品類型）
- 北美市場規模和預測（按應用）
- 北美市場規模及預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲流動止血鉗主要製造商
- 歐洲市場規模及預測（按國家/地區）
- 歐洲市場規模和預測（按產品類型）
- 歐洲市場規模和預測，按應用
- 歐洲市場規模及預測（按最終用戶）
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 瑞典
- 俄羅斯
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區流動止血鉗主要製造商
- 亞太地區市場規模及預測（依國家）
- 亞太地區市場規模及預測（依產品類型）
- 亞太地區市場規模及預測（按應用）
- 亞太地區市場規模及預測（依最終用戶）
- 中國
- 印度
- 日本
- 韓國
- 澳洲
- 印尼
- 泰國
- 菲律賓
- 亞太地區其他地區
拉丁美洲（LATAM）
- 概述
- 拉丁美洲流動止血鉗主要製造商
- 拉丁美洲市場規模及預測（按國家/地區）
- 拉丁美洲市場規模及預測（依產品類型）
- 拉丁美洲市場規模及預測（按應用）
- 拉丁美洲市場規模及預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲（MEA）
- 概述
- 中東和非洲的流動止血鉗主要製造商
- MEA 市場規模及預測（依國家/地區）
- MEA 市場規模及預測（依產品類型）
- MEA 市場規模及預測（按應用）
- MEA 市場規模及預測（依最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 其餘地區

第 11 章：關鍵供應商分析-流動止血鉗產業

競爭儀錶板
- Competitive Benchmarking
- Competitive Positioning
公司簡介
- Johnson & Johnson Services, Inc.
- Baxter International Inc.
- Becton, Dickinson and Company (BD)
- Pfizer Inc.
- Medtronic plc
- Teleflex Incorporated
- Integra LifeSciences Holdings Corporation
- Stryker Corporation
- CSL Behring LLC
- CryoLife, Inc.
- Ethicon, Inc.
- Mallinckrodt Pharmaceuticals
- Z-Medica, LLC
- Hemostasis, LLC
- Tissuemed Ltd
- Biocer Entwicklungs-GmbH

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4926

REPORT HIGHLIGHT

Flowable Hemostats Market size was valued at US$ 750.54 Million in 2024, expanding at a CAGR of 6.01% from 2025 to 2032.

The Flowable Hemostats Market focuses on products used to control bleeding during surgical procedures. Flowable hemostats are thick, gelatinous substances that combine a hemostatic agent with a carrier material, making them easy to apply to irregular wound surfaces. These hemostats work by accelerating the body's natural clotting process, helping to manage bleeding quickly and effectively. They are widely used in surgeries such as cardiovascular, orthopedic, and general procedures. The market is driven by the rising number of surgical procedures globally, an aging population, and increasing trauma cases.

Advancements in hemostatic technology, such as faster application and improved biocompatibility, are enhancing their effectiveness. Additionally, the demand for minimally invasive surgeries has boosted the use of flowable hemostats. North America and Europe currently lead the market due to advanced healthcare systems, while Asia-Pacific is experiencing rapid growth. Challenges include high costs and regulatory hurdles. However, increasing healthcare investments and innovations continue to drive market expansion.

Flowable Hemostats Market- Market Dynamics

Rising surgical procedures globally increasing demand for hemostatic solutions.

The increasing number of surgical procedures worldwide is a significant driver for the flowable hemostats market. A study published in The Lancet estimated that approximately 234 million major surgical procedures are performed globally each year. This high volume underscores the critical need for effective hemostatic agents to manage bleeding during surgeries.

Flowable hemostats, known for their ease of application and efficacy in controlling bleeding, are becoming essential tools in the surgical toolkit. As the global population ages and the prevalence of chronic diseases rises, the demand for surgical interventions is expected to increase, further propelling the need for advanced hemostatic solutions.

Flowable Hemostats Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.01% over the forecast period (2025-2032)

Based on product type segmentation, Gelatin-based hemostats was predicted to show maximum market share in the year 2024

Based on application segmentation, Cardiovascular surgery was the leading application in 2024

Based on End-user segmentation, Hospitals was the leading end-user in 2024

On the basis of region, North America was the leading revenue generator in 2024

Flowable Hemostats Market- Segmentation Analysis:

The Global Flowable Hemostats Market is segmented on the basis of Product Type, Application, End-user, and Region.

The market is divided into Four categories based on product type: Gelatin-based Hemostats, Collagen-based Hemostats, Combination Hemostats, and Thrombin-based Hemostats. Gelatin-based hemostats dominate the flowable hemostats market due to their versatility, effectiveness, and ease of use in controlling bleeding during various surgical procedures. These hemostats work by absorbing blood rapidly and creating a mechanical barrier to promote clotting. Their widespread use in cardiovascular, orthopedic, and general surgeries drives their market leadership. According to the U.S. Food and Drug Administration (FDA), gelatin-based hemostats are among the most commonly approved and utilized hemostatic agents in operating rooms. Surgeons prefer them for their biocompatibility, ease of application, and effectiveness on irregular wound surfaces. Additionally, the rising number of minimally invasive surgeries and trauma cases has further fueled their demand. Continuous advancements, such as improved formulations and faster absorption rates, are enhancing their performance, solidifying their position as the market leader.

The market is divided into two categories based on application: Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Gynecological Surgery, Urology Surgery, Other. Cardiovascular surgery dominates the flowable hemostats market due to the high volume of complex procedures requiring effective bleeding control. According to the Centers for Disease Control and Prevention (CDC), approximately 805,000 heart attacks occur annually in the U.S., driving a surge in cardiac surgeries. Flowable hemostats are crucial in these surgeries to manage bleeding in delicate and hard-to-reach areas, reducing the risk of complications. Surgeons prefer them for their ability to work on irregular surfaces and in active bleeding sites. The increasing prevalence of heart diseases, aging populations, and advancements in cardiac procedures, such as bypass surgeries and valve replacements, further boost demand. The shift towards minimally invasive cardiovascular interventions has increased the use of quick and efficient hemostatic solutions, solidifying cardiovascular surgery as the leading application segment.

Flowable Hemostats Market- Geographical Insights

North America holds a major share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare infrastructure. According to the Centers for Disease Control and Prevention (CDC), over 50 million surgical procedures are performed annually in the U.S., increasing the demand for effective hemostatic solutions. The region benefits from frequent FDA approvals, which facilitate the introduction of innovative hemostatic products. The growing prevalence of chronic diseases, such as cardiovascular disorders and cancer, has increased the number of surgeries, further driving market growth. Additionally, a rising elderly population, which is more susceptible to surgical interventions, contributes to the demand for advanced hemostats. Major players like Johnson & Johnson, Baxter, and Medtronic are heavily investing in research and development to enhance product efficacy. The increase in outpatient procedures and minimally invasive surgeries, especially in ambulatory surgical centers, has also fueled demand. Overall, strong healthcare spending and technological advancements make North America a key market for flowable hemostats.

The United States holds a significant share of the flowable hemostats market, driven by a high volume of surgical procedures and advanced healthcare facilities. According to the CDC, over 50 million surgeries are performed annually in the U.S., increasing the demand for effective bleeding control solutions. The presence of major players such as Johnson & Johnson, Baxter, and Medtronic contributes to market growth through continuous innovation and new product launches. Additionally, a growing aging population and rising prevalence of chronic diseases, such as cardiovascular disorders and cancer, are driving surgical interventions. The country's strong regulatory framework, with frequent FDA approvals, supports the rapid adoption of advanced hemostatic products. Increased funding for healthcare research and high healthcare expenditure further fuel market expansion. The rise in outpatient and minimally invasive surgeries, particularly in ambulatory surgical centers, has boosted demand for easy-to-use hemostats. Additionally, trauma cases from accidents contribute to increased usage of flowable hemostats in emergency procedures. Overall, the U.S. remains a key market with strong growth potential.

Flowable Hemostats Market- Competitive Landscape:

The flowable hemostats market is highly competitive, driven by technological advancements, product innovations, and strategic collaborations among key players. Companies are focusing on research and development to introduce hemostatic solutions with improved efficacy, faster application, and better biocompatibility. Frequent FDA approvals and new product launches are enhancing market expansion. Mergers, acquisitions, and partnerships with hospitals and surgical centers are common strategies to strengthen market presence. Leading players such as Johnson & Johnson (Ethicon), Baxter International (Floseal Hemostatic Matrix), Becton, Dickinson and Company (BD), Medtronic, and Pfizer dominate the market with a broad range of hemostatic solutions. Additionally, companies like Stryker, Teleflex, CryoLife, CSL Behring, Hemostasis, LLC, and Tissuemed Ltd are expanding their portfolios through continuous innovation. The competitive landscape is further shaped by investments in minimally invasive surgical technologies and collaborations with healthcare providers. This intense competition is driving improvements in product performance, safety, and accessibility, ensuring sustained market growth.

Recent Developments:

In April 2023, Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, including the launch of Floseal + Recothrom flowable hemostat. This helped the company to expand its product offerings and increase the reach of its product.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLOWABLE HEMOSTATS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Johnson & Johnson Services, Inc.
Baxter International Inc.
Becton, Dickinson and Company (BD)
Pfizer Inc.
Medtronic plc
Teleflex Incorporated
Integra LifeSciences Holdings Corporation
Stryker Corporation
CSL Behring LLC
CryoLife, Inc.
Ethicon, Inc.
Mallinckrodt Pharmaceuticals
Z-Medica, LLC
Hemostasis, LLC
Tissuemed Ltd
Biocer Entwicklungs-GmbH

GLOBAL FLOWABLE HEMOSTATS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Gelatin-based Hemostats
Collagen-based Hemostats
Combination Hemostats
Thrombin-based Hemostats

GLOBAL FLOWABLE HEMOSTATS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Cardiovascular Surgery
Orthopedic Surgery
General Surgery
Neurosurgery
Gynecological Surgery
Urology Surgery
Other

GLOBAL FLOWABLE HEMOSTATS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Ambulatory Surgical Centers (ASCs)
Specialty Clinics
Trauma Centers

GLOBAL FLOWABLE HEMOSTATS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Flowable Hemostats Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Flowable Hemostats Market Snippet by Product Type
- 2.1.2. Flowable Hemostats Market Snippet by Application
- 2.1.3. Flowable Hemostats Market Snippet by End-user
- 2.1.4. Flowable Hemostats Market Snippet by Country
- 2.1.5. Flowable Hemostats Market Snippet by Region
2.2. Competitive Insights

3. Flowable Hemostats Key Market Trends

3.1. Flowable Hemostats Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Flowable Hemostats Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Flowable Hemostats Market Opportunities
3.4. Flowable Hemostats Market Future Trends

4. Flowable Hemostats Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Flowable Hemostats Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. Flowable Hemostats Market Landscape

6.1. Flowable Hemostats Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Flowable Hemostats Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Gelatin-based Hemostats
- 7.1.3. Collagen-based Hemostats
- 7.1.4. Combination Hemostats
- 7.1.5. Thrombin-based Hemostats

8. Flowable Hemostats Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Cardiovascular Surgery
- 8.1.3. Orthopedic Surgery
- 8.1.4. General Surgery
- 8.1.5. Neurosurgery
- 8.1.6. Gynecological Surgery
- 8.1.7. Urology Surgery
- 8.1.8. Other

9. Flowable Hemostats Market - By End-user

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Ambulatory Surgical Centers (ASCs)
- 9.1.4. Specialty Clinics
- 9.1.5. Trauma Centers

10. Flowable Hemostats Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Flowable Hemostats Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Flowable Hemostats Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.8. UK
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.9. France
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.10. Italy
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.11. Spain
  - 10.3.11.1. Overview
  - 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.12. The Netherlands
  - 10.3.12.1. Overview
  - 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Overview
  - 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.14. Russia
  - 10.3.14.1. Overview
  - 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.15. Poland
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.3.16. Rest of Europe
  - 10.3.16.1. Overview
  - 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Flowable Hemostats Key Manufacturers in Asia Pacific
- 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.7. China
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.8. India
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.12. Indonesia
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.13. Thailand
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
- 10.5.1. Overview
- 10.5.2. Flowable Hemostats Key Manufacturers in Latin America
- 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
- 10.6.1. Overview
- 10.6.2. Flowable Hemostats Key Manufacturers in Middle East and Africa
- 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.8. UAE
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Flowable Hemostats Industry

11.1. Competitive Dashboard
- 11.1.1. Competitive Benchmarking
- 11.1.2. Competitive Positioning
11.2. Company Profiles
- 11.2.1. Johnson & Johnson Services, Inc.
- 11.2.2. Baxter International Inc.
- 11.2.3. Becton, Dickinson and Company (BD)
- 11.2.4. Pfizer Inc.
- 11.2.5. Medtronic plc
- 11.2.6. Teleflex Incorporated
- 11.2.7. Integra LifeSciences Holdings Corporation
- 11.2.8. Stryker Corporation
- 11.2.9. CSL Behring LLC
- 11.2.10. CryoLife, Inc.
- 11.2.11. Ethicon, Inc.
- 11.2.12. Mallinckrodt Pharmaceuticals
- 11.2.13. Z-Medica, LLC
- 11.2.14. Hemostasis, LLC
- 11.2.15. Tissuemed Ltd
- 11.2.16. Biocer Entwicklungs-GmbH